Linagliptin treatment in subjects with type 2 diabetes with and without mild‐to‐moderate renal impairment期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Linagliptin treatment in subjects with type 2 diabetes with and without mild‐to‐moderate renal impairment

Authors:	P.‐H. Groop S. Del Prato M.‐R. Taskinen D. R. Owens Y. Gong S. Crowe S. Patel M. von Eynatten H.‐J. Woerle

Affiliation:	1. Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, , Helsinki, Finland;2. Folkh?lsan Institute of Genetics, Folkh?lsan Research Center, Biomedicum Helsinki, , Helsinki, Finland;3. Baker IDI Heart and Diabetes Institute, Melbourne, , Victoria, Australia;4. Department of Clinical and Experimental Medicine, University of Pisa, , Pisa, Italy;5. Diabetes Research Group, Swansea University, , Swansea, UK;6. Boehringer Ingelheim Pharma GmbH & Co. KG, , Ingelheim, Germany;7. Boehringer Ingelheim Ltd, , Bracknell, UK

Abstract:

Keywords:	diabetic nephropathy DPP‐4 inhibitor glycaemic control incretin therapy type 2 diabetes